Dr. Feldman received his undergraduate and medical training at Indiana University, completing residency as Chief Resident at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois. After finishing his Cardiology Fellowship at the University of Chicago, he remained there as Professor of Medicine and Director of the Cardiac Catheterization Laboratory. He currently practices at Evanston Hospital, where he is Director of the Cardiac Catheterization Laboratory, holds the Walgreen Chair in Interventional Cardiology, and is Professor of Clinical Medicine at University of Chicago Medical School. He has authored over 600 manuscripts, chapters, abstracts, and editorials and edited or co-edited several books. He is a Percutaneous Coronary Intervention Guideline co-author and has served on the American Board of Internal Medicine Interventional Cardiology test writing committee. Chicago Magazine has repeatedly named him among Chicago’s Top Doctors. Dr. Feldman is a past-President of the Society of Cardiovascular Angiography & Interventions (SCAI), and chaired the Annual Scientific Sessions of the Society, as well as the American College of Cardiology Annual Meeting Interventional Sessions. He is an active interventional practitioner and performs hundreds of catheter procedures every year and is a Master Fellow the SCAI. He has been the national principal investigator of the EVEREST I and II MitraClip trials, REPRISE III TAVR trial, and CorVia REDUCE LAP trial. He participates in numerous clinical investigations, with major research interests that include non-surgical, percutaneous repair and replacement of the mitral valve, catheter based aortic valve replacement, device closure for paravalavular leak and congenital heart disease, left atrial appendage closure, and development of novel catheter devices.